Skip to contentBERNS PAUL L — Anacor Pharmaceuticals Inc insider: 271 transactions · InsiderLensBERNS PAUL L
- Chief Executive Officer at ALLOS THERAPEUTICS INC · on record since Mar 13, 2006
- Director at Neumora Therapeutics, Inc. · on record since Sep 14, 2023
- Director at XENOPORT INC · on record since May 4, 2006
- Director at Metsera, Inc. · on record since Jan 30, 2025
- 10% owner at Metsera, Inc. · on record since Jan 30, 2025
- See Remarks at Neumora Therapeutics, Inc. · on record since Feb 20, 2025
- 10% owner at Lyell Immunopharma, Inc. · on record since Jul 29, 2025
- Director at Kardigan, Inc. · on record since Jun 18, 2026
- 10% owner at Kardigan, Inc. · on record since Jun 18, 2026
- Director at Blockchain Industries, Inc. · on record since Jul 25, 2003
- Director at JAZZ PHARMACEUTICALS INC · on record since Jun 8, 2010
- President/CEO at Blockchain Industries, Inc. · on record since Jun 24, 2004
- Director at Anacor Pharmaceuticals Inc · on record since Jun 1, 2012
- President and CEO at Anacor Pharmaceuticals Inc · on record since Mar 25, 2014
- Director at Cellectar Biosciences, Inc. · on record since Aug 18, 2014
- Director at VYNE Therapeutics Inc. · on record since Jan 24, 2018
- Director at Unity Biotechnology, Inc. · on record since May 7, 2018
- Director at Camelot Entertainment Group, Inc. · on record since Dec 21, 2021
Insider trading activity of BERNS PAUL L
- Transactions on record
- 271
- since Jun 25, 2004
- Open-market buys
- 7
- $27M
- Open-market sells
- 77
- $25M
- Companies traded
- 13
- last filing Jun 24, 2026
Figures computed from official regulatory filings — methodology.
Companies where BERNS PAUL L has traded
- Kardigan, Inc.6 tx · Jun 24, 2026
- Lyell Immunopharma, Inc.1 tx · $12.5M · Mar 9, 2026
- Neumora Therapeutics, Inc.23 tx · $57.9K · Feb 19, 2026
- Metsera, Inc.12 tx · $14.2M · Nov 13, 2025
- Unity Biotechnology, Inc.8 tx · Jun 21, 2024
- Camelot Entertainment Group, Inc.7 tx · Nov 9, 2023
- JAZZ PHARMACEUTICALS INC54 tx · $5.4M · Aug 9, 2021
- VYNE Therapeutics Inc.2 tx · Aug 8, 2019
- Anacor Pharmaceuticals Inc55 tx · $47.3M · Jun 24, 2016
Track record of BERNS PAUL L
Statistical track record
Free- Open-market buys
- 8
- Last buy
- Jun 22, 2026
Win rates and median returns are available with a free account (5 insiders/month).
Create a free account→Transaction history of BERNS PAUL L
Co-insiders of BERNS PAUL L
- Burow KristinaKardigan, Inc. +4
- CRANDELL KEITHKardigan, Inc. +4
- NELSEN ROBERTKardigan, Inc. +4
- GILLIS STEVENKardigan, Inc. +3
- ARCH Venture Fund XIII, L.P.Kardigan, Inc. +2
- ARCH Venture Partners XIII, LLCKardigan, Inc. +2
- ARCH Venture Partners XIII, L.P.Kardigan, Inc. +2
This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →
34 tx · $866.6K · May 19, 2016
BYBEE CLINTONLyell Immunopharma, Inc. +2
| Company | Filed | Type | Qty | Price | Value · USD | Src |
|---|
| Jun 24, 2026 | Buy | 1,250,000 | 16.00 USD | — | SEC |
| Jun 22, 2026 | Other | 13,792,035 | — | — | SEC |
| Jun 22, 2026 | Award | 20,706 | 0.00 USD | — | SEC |
| Jun 22, 2026 | OtherD | -2,306,401 | — | — | SEC |
| Jun 22, 2026 | OtherD | -5,148,587 | — | — | SEC |
| Jun 22, 2026 | OtherD | -1,204,000 | — | — | SEC |
| Mar 9, 2026 | Buy | 488,090 | 25.61 USD | $12.5M | SEC |
| Feb 19, 2026 | Sell | -9,819 | 3.51 USD | $34.5K | SEC |
| Jan 9, 2026 | AwardD | 1,650,000 | 0.00 USD | $0 | SEC |
| Nov 13, 2025 | AwardD | 4,031 | — | — | SEC |
| Nov 13, 2025 | Other | -957,559 | — | — | SEC |
| Nov 13, 2025 | Other | -4,031 | — | — | SEC |
| Nov 13, 2025 | Other | -7,523,682 | — | — | SEC |
| Nov 13, 2025 | Other | -8,313,680 | — | — | SEC |
| Nov 13, 2025 | OtherD | -24,188 | — | — | SEC |
| Nov 13, 2025 | OtherD | -223,430 | — | — | SEC |
| May 30, 2025 | AwardD | 342,500 | — | — | SEC |
| May 30, 2025 | OtherD | -342,500 | — | — | SEC |
| May 30, 2025 | OtherD | -955,864 | — | — | SEC |
| May 30, 2025 | AwardD | 497,049 | — | — | SEC |
| May 30, 2025 | AwardD | 955,864 | — | — | SEC |
| May 30, 2025 | OtherD | -497,049 | — | — | SEC |
| May 30, 2025 | AwardD | 2,000,000 | — | — | SEC |
| May 30, 2025 | OtherD | -2,000,000 | — | — | SEC |
| May 22, 2025 | AwardD | 24,188 | 0.00 USD | $0 | SEC |